Background Sub-Saharan Africa has the highest burden of malaria in the world. Artemisinin-
based combination therapies (ACTs) have been the cornerstone in the efforts to reduce the …

Background Malaria is a major cause of morbidity and mortality in pediatrics in malaria
endemic areas. Artemisinin-based combination therapies (ACTs) are the drugs of choice for …

Patients with cerebral malaria (CM) are unable to take oral medication due to impaired
consciousness and vomiting thus necessitating parenteral therapy. Quinine, artemether, and …

Abstract Background Since 2005, the Togo National Malaria Control Programme has
recommended two different formulations of artemisinin-based combination therapy (ACT) …

Background Plasmodium falciparum malaria is associated with anaemia-related morbidity,
attributable to host, parasite and drug factors. We quantified the haematological response …

The development of artemisinin resistance in the Greater Mekong Subregion poses a
significant threat to malaria elimination. Artemisinin-based combination therapies including …

Background Current day malaria cases and deaths are indicative of a lack of access to both
methods of prevention, diagnosis, and treatment; an important determinant of treatment …

Aims and Objectives: The study was designed with the broad objective of determining the
safety profile of artemisinin-based combination therapies amongst Nigerian population …

Antimalarial drugs are being encapsulated in nanotechnology-based carriers because there
are not enough new treatment options and people are becoming more resistant to the ones …

The knowledge, prevention and practices on malaria treatment measures were assessed
among 643 tertiary students in Osun and Oyo States in Nigeria. Data were collected using …